Inhibition of human immunodeficiency virus proliferation by macrocyclic polyamines and their metal complexes
- PMID: 7515743
- DOI: 10.1248/bpb.17.243
Inhibition of human immunodeficiency virus proliferation by macrocyclic polyamines and their metal complexes
Abstract
The macrocyclic polyamines, cyclen and cyclam, and their derivatives have been tested for inhibitory activity against the cytopathogenic effect (CPE) of human immunodeficiency virus type 1 strain HTLV-IIIB (HIV-1IIIB) on CD4+ human lymphoblastoma MT-4 cells. Cyclam and its derivatives were complexed with a variety of transition metal ions NiII, ZnII, CuII, FeIII and CoIII. The divalent metal complexes effected lower toxicity and greater anti-HIV-1 activity, while the trivalent metal complexes had no effect on HIV-1-dependent CPE. When dimerized, the anti-HIV activity of monomers was significantly enhanced. A potent inhibition of CPE by biscyclam was transiently observed 4 d after the virus infection, but was not seen at 6 d due to severe toxicity. The toxicity of biscyclam, referred to as delayed toxicity, could be overcome by a metal complexation. The strain specificities of biscyclams were further studied by testing their effects on syncytium formation between HIV-infected and uninfected human acute lymphoblastic leukemia MOLT-4 cells. The 50% inhibitory concentrations of biscyclams against HIV-2GH-1-dependent syncytium formation were less than one hundredth those for the other HIV strains (HIV-1IIIB, HIV-1RF and HIV-1SF-2).
Similar articles
-
Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by daphnodorins.Antiviral Res. 1994 Sep;25(1):57-66. doi: 10.1016/0166-3542(94)90093-0. Antiviral Res. 1994. PMID: 7529015
-
Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.Mol Pharmacol. 1992 Dec;42(6):1109-17. Mol Pharmacol. 1992. PMID: 1282664
-
Anti-human immunodeficiency virus effects of cationic metalloporphyrin-ellipticine complexes.Biochem Pharmacol. 1992 Oct 20;44(8):1675-9. doi: 10.1016/0006-2952(92)90486-3. Biochem Pharmacol. 1992. PMID: 1384504
-
Cyclam complexes and their applications in medicine.Chem Soc Rev. 2004 May 10;33(4):246-66. doi: 10.1039/b313659k. Epub 2004 Mar 22. Chem Soc Rev. 2004. PMID: 15103406 Review.
-
[Creation of new supramolecular science with macrocyclic polyamines].Yakugaku Zasshi. 1996 Aug;116(8):587-605. doi: 10.1248/yakushi1947.116.8_587. Yakugaku Zasshi. 1996. PMID: 8831261 Review. Japanese.
Cited by
-
Oxovanadium(IV) cyclam and bicyclam complexes: potential CXCR4 receptor antagonists.Inorg Chem. 2010 Feb 1;49(3):1122-32. doi: 10.1021/ic9020614. Inorg Chem. 2010. PMID: 20039648 Free PMC article.
-
Inhibition of HBV infection by bovine lactoferrin and iron-, zinc-saturated lactoferrin.Med Microbiol Immunol. 2009 Feb;198(1):19-25. doi: 10.1007/s00430-008-0100-7. Epub 2008 Sep 23. Med Microbiol Immunol. 2009. PMID: 18810491
-
Design, Synthesis, and Biological Evaluation of Boron-Containing Macrocyclic Polyamines and Their Zinc(II) Complexes for Boron Neutron Capture Therapy.J Med Chem. 2021 Jun 24;64(12):8523-8544. doi: 10.1021/acs.jmedchem.1c00445. Epub 2021 Jun 2. J Med Chem. 2021. PMID: 34077212 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous